Dáil Éireann Debate, Thursday - 26 May 2016
193. Deputy Billy Kelleher asked the Minister for Health the average sums the Health Service Executive paid for a typical course of fidaxomicin, vancomycin and other drugs used for persons infected with clostridium difficile and methicillin resistant staphylococcus aureus, MRSA, in hospitals under its control, by patient, in each of the years 2011 to 2016 to date, in tabular form; and if he will make a statement on the matter. [12325/16]
View answer194. Deputy Billy Kelleher asked the Minister for Health the sums the Health Service Executive paid for fidaxomicin, vancomycin and other drugs in treating patients for infection with Clostridium difficile and methicillin resistant staphylococcus aureus, MRSA, in hospitals under its control in each of the years 2011 to 2016 to date, in tabular form; and if he will make a statement on the matter. [12326/16]
View answerI propose to take Questions Nos. 193 and 194 together.
As these are service matters, I have asked the HSE to respond to you directly. If you have not received a reply from the HSE within 15 working days please contact my Private Office and my officials will follow the matter up.
